{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:31:09Z","timestamp":1794047469196,"version":"4.8.0"},"reference-count":14,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"6","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"DOI":"10.3324\/haematol.2023.284282","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T05:38:08Z","timestamp":1706765888000},"page":"1956-1959","source":"Crossref","is-referenced-by-count":1,"title":["Update and European consensus on a patient-centered core outcome set for multiple myeloma in clinical practice and research"],"prefix":"10.3324","volume":"109","author":[{"given":"Simone","family":"Oerlemans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belle H.","family":"De Rooij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Bennink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Bullinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemiek","family":"Broijl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"D\u2019Agostino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Laane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Lupo-Stanghellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Perrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Wester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viorica","family":"Cursaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Scheurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Vesseur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehul","family":"Dalal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohini","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Stamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Sonneveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2024,2,1]]},"reference":[{"key":"62437","doi-asserted-by":"crossref","unstructured":"Porter ME. What is value in health care?. N Engl J Med. 2010; 363(26):2477-2481.","DOI":"10.1056\/NEJMp1011024"},{"key":"62438","doi-asserted-by":"crossref","unstructured":"Blade J, Calleja MA, Lahuerta JJ, Poveda JL, de Paz HD, Lizan L. Defining a set of standardised outcome measures for newly diagnosed patients with multiple myeloma using the Delphi consensus method: the IMPORTA project. BMJ Open. 2018; 8(2):e018850.","DOI":"10.1136\/bmjopen-2017-018850"},{"key":"62439","doi-asserted-by":"crossref","unstructured":"Lang KM, Bereczky T, Geissler J. Pan-stakeholder Core Outcome Set (COS) definition for hematological malignancies within the Framework of Harmony and Harmony PLUS projects. Blood. 2022; 140(Suppl 1):5285-5287.","DOI":"10.1182\/blood-2022-157549"},{"key":"62440","doi-asserted-by":"crossref","unstructured":"Oerlemans S, Bennink MC, Levin MD. Development of a patient centered outcome set for patients with multiple myeloma to be used in clinical practice. Hemasphere. 2020; 4(3):e366.","DOI":"10.1097\/HS9.0000000000000366"},{"key":"62441","doi-asserted-by":"crossref","unstructured":"Ludwig H, Novis Durie S, Meckl A, Hinke A, Durie B. Multiple myeloma incidence and mortality around the globe; interrelations between health access and quality, economic resources, and patient empowerment. Oncologist. 2020; 25(9):e1406-e1413.","DOI":"10.1634\/theoncologist.2020-0141"},{"key":"62442","doi-asserted-by":"crossref","unstructured":"Cavo M, Gay F, Beksac M. Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02\/ HO95): a multicentre, randomised, open-label, phase 3 study. Lancet Haematol. 2020; 7(6):e456-e468.","DOI":"10.1016\/S2352-3026(20)30099-5"},{"key":"62443","doi-asserted-by":"crossref","unstructured":"Dimopoulos MA, Moreau P, Terpos E. Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2021; 32(3):309-322.","DOI":"10.1016\/j.annonc.2020.11.014"},{"key":"62444","doi-asserted-by":"crossref","unstructured":"van de Donk N, Pawlyn C, Yong KL. Multiple myeloma. Lancet. 2021; 397(10272):410-427.","DOI":"10.1016\/S0140-6736(21)00135-5"},{"key":"62445","doi-asserted-by":"crossref","unstructured":"Terpos E, Mikhael J, Hajek R. Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life. Blood Cancer J. 2021; 11(2):40.","DOI":"10.1038\/s41408-021-00432-4"},{"key":"62446","doi-asserted-by":"crossref","unstructured":"Ojo AS, Araoye MO, Ali A, Sarma R. The impact of current therapeutic options on the health-related quality of life of patients with relapse\/refractory multiple myeloma: a systematic review of clinical studies. J Cancer Surviv. 2023.","DOI":"10.1007\/s11764-023-01332-1"},{"key":"62447","doi-asserted-by":"crossref","unstructured":"Ramsenthaler C, Osborne TR, Gao W. The impact of disease-related symptoms and palliative care concerns on health-related quality of life in multiple myeloma: a multicentre study. BMC Cancer. 2016; 16:427.","DOI":"10.1186\/s12885-016-2410-2"},{"key":"62448","doi-asserted-by":"crossref","unstructured":"Fragola M. Patient-reported outcomes and assessment of quality of life: a focus on multiple myeloma. J Adv Pract Oncol. 2020; 11(5):513-520.","DOI":"10.6004\/jadpro.2020.11.5.7"},{"key":"62449","doi-asserted-by":"crossref","unstructured":"Salek S, Ionova T, Oliva EN. The reporting, use, and validity of patient-reported outcomes in multiple myeloma in clinical trials: a systematic literature review. Cancers (Basel). 2022; 14(23):6007.","DOI":"10.3390\/cancers14236007"},{"key":"62450","unstructured":"Stamm T, Bott N, Thwaites R. Building a value-based care infrastructure in Europe: the Health Outcomes Observatory. NEJM Catalyst. 2021; 2(3):1148-1156."}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.284282\/76596","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.284282\/77085","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11431\/76596","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:05:37Z","timestamp":1794045937000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2023.284282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":14,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2023.284282","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,1]]}}}